Table 1 Patient characteristics.
Treatment | ||||
|---|---|---|---|---|
Surgery | CCRT | p -value | ||
No.(%) | No.(%) | |||
No. of patients | 14(30) | 33(70) | ||
Sex | male | 13(93) | 32(97) | 0.523 |
female | 1(7) | 1(3) | ||
Age(y) | ≥ 60 | 7(50) | 14(42) | 0.633 |
< 60 | 7(50) | 19(58) | ||
Median | 58 | 57 | ||
Range | 43-73 | 40-71 | ||
Performance (ECOG) | 0 | 10 | 23 | 0.805 |
1 | 4 | 9 | ||
2 | 0 | 1 | ||
Location | Pyriform sinus | 11(79) | 30(91) | 0.085 |
Pharyngeal wall | 0(0) | 2(6) | ||
Post-cricoid | 3(21) | 1(3) | ||
Histology grade | 1-2 | 8(57) | 20(61) | 0.292 |
3 | 6(43) | 9(27) | ||
NA | 0(0) | 4(12) | ||
cT | 1 | 0 | 1(3) | 0.795 |
2 | 3(21) | 7(21) | ||
3 | 4(29) | 6(18) | ||
4a | 7(50) | 19(58) | ||
cN | 0 | 5(36) | 9(27) | 0.488 |
1 | 1(7) | 7(21) | ||
2a-2c | 8(57) | 17(52) | ||
Clinical stage | II | 2(14) | 2(6) | 0.652 |
III | 2(14) | 5(15) | ||
IVA | 10(71) | 26(79) | ||
cTCI | Yes | 7(50) | 19(58) | 0.633 |
No | 7(50) | 14(42) | ||
cCCI | Yes | 2(14) | 7(21) | 0.581 |
No | 12(86) | 26(79) | ||
RT dose(Gy) | Median | 62 | 70 | |
Range | 60-70 | 70-75 | ||
Follow-up time(m) | Median | 19.8 | 18.8 | |
Range | 6.7-67.9 | 1.9-72.3 | ||